RXRX:NASDAQ
Recursion Pharmaceuticals Inc
$4.12
arrow_upward
+1.23%(+0.050) 1D
$4.12
arrow_upward
+0.12% (+0.0050)bedtimeAfter hours
Closed: Oct 2, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RXRX...
Open
$4.18
High
$4.27
Low
$4.01
Mkt. cap
2.21B
Avg. vol.
19.27M
Volume
18.84M
52-wk high
$7.18
52-wk low
$2.77
EPS
-$1.04
Beta
1.04
Shares outstanding
535.34M
No. of employees
600
Open
$4.18
High
$4.27
Low
$4.01
Mkt. cap
2.21B
Avg. vol.
19.27M
Volume
18.84M
52-wk high
$7.18
52-wk low
$2.77
EPS
-$1.04
Beta
1.04
Shares outstanding
535.34M
No. of employees
600
News stories
From web sources and news partners
Simply Wall Street
·
8 hours ago
Could Tempus RNA License Alter The Investment Case For Recursion Pharmaceuticals (RXRX)?
Investing.com Canada
·
17 hours ago
Form 4 Recursion Pharmaceuticals Inc For: 2 October By Investing.com
Stock Titan
·
20 hours ago
Dean Y. Li receives 3,378 Recursion (RXRX) shares under its Outside Director Compensation Policy.
TradingView
·
1 day ago
Most and least shorted mid- to mega-cap healthcare stocks at the end of September
About Recursion Pharmaceuticals Inc
CEONajat Khan
Employees600
Founded2013
HeadquartersSalt Lake City, Utah, United States
SectorBiotechnology
Websiterecursion.com